ACADIA Pharmaceuticals financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$4.60M $10.96M $8.13M $7.56M $1.59M $6.40M $42.14M $2.07M $4.91M $1.15M $0.12M $0.06M $17.33M $124.90M $223.81M $339.08M $441.76M $484.15M $517.24M $726.44M $0.00M
GM % Gross Margin %
0.00% -152.79% 0.00% 0.00% 0.00% 0.00% 51.16% 0.00% -283.00% 0.00% 0.00% 0.00% 0.00% -29.90% 8.18% 23.33% 35.06% 46.60% 28.13% 45.86% 0.00%
OM Operating Margin
0.00% -270.03% 0.00% 0.00% 0.00% 0.00% 35.82% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -234.11% -110.56% -72.71% -52.92% -35.20% -43.23% -10.10% 0.00%
EPS Earnings Per Share
$-1.27 $-1.61 $-1.60 $-1.73 $-1.17 $0.39 $-0.44 $-0.38 $-0.44 $-0.95 $-1.63 $-2.34 $-2.36 $-1.94 $-1.60 $-1.79 $-1.05 $-1.34 $-0.37 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 -0.00% -0.00% -0.00% 0.00% 0 0 0 0 -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% 0
Sha. Shares
16.87m 23.49m 29.8m 36.97m 37.14m 38.27m 39.3m 52.8m 78.64m 90.87m 99.77m 100.91m 121.11m 124.21m 143.63m 154.03m 158.98m 160.76m 161.43m 164.18m 164.18m
OCF Operating Cash Flow
$-20.69M $-20.26M $-41.42M $-54.93M $-64.87M $-13.73M $-10.70M $-19.90M $-21.63M $-31.77M $-66.43M $-121.80M $-208.41M $-217.76M $-167.47M $-151.13M $-136.17M $-125.66M $-114.04M $16.70M $0.00M
FCF Free Cash Flow
$-21.28M $-21.28M $-43.45M $-55.35M $-65.10M $-13.77M $0.00M $0.00M $0.00M $-32.39M $-66.61M $-123.94M $-211.91M $-218.67M $-169.62M $-152.26M $-143.75M $-126.78M $-114.04M $-70.75M $0.00M
FCFS Free Cash Flow Per Share
$-2.06 $-0.97 $-1.56 $-1.57 $-1.75 $-0.37 $-0.28 $-0.38 $-0.39 $-0.38 $-0.68 $-1.23 $-1.88 $-1.78 $-1.34 $-1.03 $-0.91 $-0.79 $-0.71 $-0.14 $0.00